Cargando…
Oncolytic Virotherapy Treatment of Breast Cancer: Barriers and Recent Advances
Oncolytic virotherapy (OV) is an emerging class of immunotherapeutic drugs. Their mechanism of action is two-fold: direct cell lysis and unmasking of the cancer through immunogenic cell death, which allows the immune system to recognize and eradicate tumours. Breast cancer is the most common cancer...
Autores principales: | Kwan, Amy, Winder, Natalie, Muthana, Munitta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230950/ https://www.ncbi.nlm.nih.gov/pubmed/34208264 http://dx.doi.org/10.3390/v13061128 |
Ejemplares similares
-
Oncolytic Sendai virus-based virotherapy for cancer: recent advances
por: Saga, Kotaro, et al.
Publicado: (2015) -
Oncolytic virotherapy for human malignant mesothelioma: recent advances
por: Boisgerault, Nicolas, et al.
Publicado: (2015) -
Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances
por: Simpson, Guy R, et al.
Publicado: (2016) -
On the potential of oncolytic virotherapy for the treatment of canine cancers
por: MacNeill, Amy L
Publicado: (2015) -
Oncolytic Virotherapy for Breast Cancer Treatment
por: O’Bryan, Samia M., et al.
Publicado: (2018)